Todd Newton

CIK 1460878 · Interim CEO · last filed 2026-06-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.14M

Companies

4

Total Filings

25

Lifetime Open-Market Net

$1.46M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MDXG Interim CEO 463,684 $3.60 $1.67M $0 9 2026-06-12
Apollo Endosurgery, Inc. (APEN) Delisted Chief Executive Officer 412,306 $10.00 $4.12M $1.25M 10 2021-01-07
Apollo Endosurgery, Inc. (LPTN) Delisted Chief Executive Officer 28,645 $0 1 2016-12-29
ARTC SVP, CFO & COO 47,214 $9.92 $468.4K $203.6K 5 2013-06-21

Recent Filings · Page 3 of 3

25 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2013-06-21 ARTC Grant (A) +9,426 $9 EDGAR
2012-03-01 ARTC Mixed +13,457 $104.8K EDGAR
2011-02-22 ARTC Grant (A) +5,886 $6 EDGAR
2010-11-05 ARTC Buy (P) +3,500 $98.8K EDGAR
2009-12-18 ARTC Grant (A) +15,000 $15 EDGAR
Showing 2125 of 25
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.